Acute myeloblastic leukemia, in relapse. C92.02 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM C92.02 became effective on October 1, 2019. This is the American ICD-10-CM version of C92.02 - other international versions of ICD-10 C92.02 may differ.
Acute myeloblastic leukemia. Acute leukemia arising from myeloid tissue in which the granular, polymorphonuclear leukocytes and their precursors predominate. An acute myeloid leukemia (aml) characterized by blasts with evidence of maturation to more mature neutrophils. Patients often present with anemia, neutropenia, and thrombocytopenia.
204.02 is a legacy non-billable code used to specify a medical diagnosis of acute lymphoid leukemia, in relapse. This code was replaced on September 30, 2015 by its ICD-10 equivalent.
There are 3 ICD-9-CM codes below 205.0 that define this diagnosis in greater detail. Do not use this code on a reimbursement claim. A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues.
C95. 9 - Leukemia, unspecified. ICD-10-CM.
ICD-9-CM Codes 204.0 (lymphoid leukemia, acute…) C91. 1 (chronic lymphocytic leukemia of B- cell type…) 204.1 (lymphoid leukemia, chronic…)
Acute myelomonocytic leukemia, not having achieved remission C92. 50 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C92. 50 became effective on October 1, 2021.
ICD-10-CM Code for Acute lymphoblastic leukemia [ALL] C91. 0.
ICD-10 code Z51. 11 for Encounter for antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Acute myeloblastic leukemia, not having achieved remission 00 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C92. 00 became effective on October 1, 2021. This is the American ICD-10-CM version of C92.
Acute myelomonocytic leukaemia (AMML) is a rare type of acute myeloid leukaemia (AML) in which there is an increased production of immature neutrophil white blood cells and immature monocyte white blood cells in the bone marrow. These immature cancerous cells are called blasts.
ICD-10 code D89. 811 for Chronic graft-versus-host disease is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .
204.02 is a legacy non-billable code used to specify a medical diagnosis of acute lymphoid leukemia, in relapse. This code was replaced on September 30, 2015 by its ICD-10 equivalent.
The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.
Acute myeloid leukemia (AML), also known as acute myelogenous leukemia or acute nonlymphocytic leukemia (ANLL), is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells.
DRG Group #820-822 - Lymphoma and leukemia with major operating room procedure with MCC.
This is the official approximate match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that while there is no exact mapping between this ICD10 code C92.02 and a single ICD9 code, 205.02 is an approximate match for comparison and conversion purposes.
207.22 is a legacy non-billable code used to specify a medical diagnosis of megakaryocytic leukemia, in relapse. This code was replaced on September 30, 2015 by its ICD-10 equivalent.
The following crosswalk between ICD-9 to ICD-10 is based based on the General Equivalence Mappings (GEMS) information:
Leukemia is cancer of the white blood cells. White blood cells help your body fight infection. Your blood cells form in your bone marrow. In leukemia, however, the bone marrow produces abnormal white blood cells. These cells crowd out the healthy blood cells, making it hard for blood to do its work.
General Equivalence Map Definitions The ICD-9 and ICD-10 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.